Palo Alto Networks® (NYSE: PANW), the next-generation security company, today announced the latest edition of its Application Usage and Threat Report (AUTR) completed by the Palo Alto Networks Unit 42 Threat Intelligence team.
The report, based on data from more than 7,000 enterprises worldwide, showcases real-world trends in enterprise application usage and critical developments in how attackers are attempting to infect organizations. It also offers practical recommendations for preventing cyberattacks.
Findings highlight the explosion in adoption of software as a service (SaaS) based applications, with the potential to introduce new security risks, or allow unauthorized access to sensitive data. Through the report, security organizations also gain insight into how long-standing and common attack vectors, such as email and executable files, continue to present challenges, as well as global application usage trends for high-risk categories, such as remote access applications.
To view the multimedia release go to:
http://www.multivu.com/players/English/7049352-palo-alto-networks-autr/
https://youtu.be/CsF6J4JwuX4 It’s common knowledge that your computer can be hacked, but are you aware of the bevy of devices, items and industries that are also at risk of attack? In this new world of the Internet of Things, everyday life is made easier, but also more vulnerable. Here are 14 things you probably didn’t know could be hacked.
Closing the distance from farm to fork, America’s turkey farmers, represented by the National Turkey Federation, have prepared a new series of videos and resources offering common-sense answers about raising healthy turkey flocks on family farms. Viewers see turkeys walk about freely and safely inside barns without cages, as well as learn how veterinarian-prescribed antibiotics are proven to clear an animal’s system before the meat is processed. The videos also share how healthy turkeys are raised on a nutritious diet of corn and soybeans along with vitamins and minerals, and how turkeys are farm-raised using smart technology and responsible stewardship of resources.
To view the multimedia release go to:
https://www.multivu.com/players/English/8113451-americas-turkey-farmers-video-series/
Soy consumption is up 14 percent since 2011,26 yet confusion lingers over soy’s role in everything from human health to food production. To clear up misperceptions, the United Soybean Board (USB) busts five common soy myths with science-backed facts on SoyConnection.com/soy-wisdom.
1) Eating soy does not increase breast cancer risk.
Clinical studies show soy isoflavone exposure does not adversely affect breast tissue as assessed by markers of breast cancer risk, such as breast cell proliferation.1–7 The American Institute for Cancer Research and the American Cancer Society say that women who have been diagnosed with breast cancer can safely consume soyfoods. In fact, the World Cancer Research Fund International has identified a link between soy consumption and an improved survival of breast cancer patients.8-9
“Not only does evidence indicate soyfoods may benefit women with breast cancer, but consuming soy when young helps prevent the onset of this disease later in life27-30,” stated Mark Messina, Ph.D., who has dedicated the past 30 years to understanding the health effects of soyfoods.
To view the multimedia release go to:
http://www.multivu.com/players/English/7877951-united-soybean-board-top-soy-myths/
The first comprehensive long-term study comparing different medications for type 2 diabetes is launching nationwide. The GRADE (Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness) Study will compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes.
To view Multimedia News Release, go to http://www.multivu.com/mnr/64578-grade-glycemia-reduction-approaches-in-diabetes-comparative-effectiveness
A first-of-a-kind neural stem cell therapy that works with a common cold virus to seek out and attack a lethal and aggressive brain cancer is being tested at Northwestern Medicine in a Phase I clinical trial for patients newly diagnosed with malignant glioma.
The novel drug to treat malignant glioma, notorious for recurring after typical bouts of standard cancer treatment, was developed by a Northwestern scientist and has been approved as an investigational drug by the U.S. Food and Drug Administration. This is only the second time the University has supported and filed an investigational new drug as a sponsor.
To view the multimedia release go to:
https://www.multivu.com/players/English/7944251-northwestern-medicine-stem-cell-trial/
According to recent survey by Medicomp Systems, 43 percent of healthcare IT professionals and physicians cited that their top data-related challenge was not a lack of data but rather the struggle to access the right data at the right time. Those findings aren't surprising since the vast majority of health information systems today share a common design flaw: they don't think and work the way physicians do at the point of care. However, they are still deeply concerning.
To deliver the best patient care, physicians need clinically relevant data that is seamlessly presented within their current workflows and integrated into the same workspace. The result is not only better patient care and better outcomes but also higher clinical effectiveness, efficiency, and satisfaction.
To view the multimedia release go to:
https://www.multivu.com/players/English/8189651-medicomp-systems-ebook-healthcare-data-challenges/
Oro Valley Audiology
2542 E Vistoso Commerce Loop Rd, Tucson, AZ 85755, USA
(520) 825-4770
https://hearintucson.com/tinnitus/
https://www.google.com/maps?cid=7471816986561274177
https://www.google.com/search?q=Oro+Valley+Audiology&kponly&kgmid=/g/1thx4hd3
Tinnitus is the perception of sound or ringing in the ears. A common problem, ringing in the ears impacts about 15 to 20 percent of individuals. Ringing in the ears isn't a condition itself-- it's a symptom of a hidden condition, such as age-related hearing loss, ear injury or a circulatory system disorder. Although annoying, tinnitus usually isn't a sign of something serious.
The complete solution to managing vaginal dryness and discomfort inside and out is now available to the millions of women changing physically, emotionally and hormonally every day. The maker of #1 doctor recommended Replens™ vaginal moisturizer introduces hormone-free and fragrance-free Replens™ Moisture Restore External Comfort Gel, for soothing relief from external vaginal dryness, in menopause, post-partum, and after a cancer diagnosis.
“Ladies, don’t despair. Vaginal dryness can be a nuisance at any age. It’s one of the most common symptoms of menopause and unfortunately, can worsen over time. Luckily, there are non-hormonal products like Replens,” says Mary Jane Minkin, M.D., Clinical Professor of Obstetrics, Gynecology and Reproductive Sciences at Yale University. “I recommend these products to patients as first line therapies to help relieve internal and external vaginal dryness.”
To view the multimedia release go to:
https://www.multivu.com/players/English/8066251-replens-vaginal-moisture-restore-external-comfort-gel/
https://youtu.be/KefLEPm6yj0 A landing page is the place where you send traffic and its main purpose is to get visitors to take some kind of action. It can be a sales page, or an email opt-in page, for example. You can use content, video, or Fiverr infographics. The landing page has to rank well with search engines so you can get more visitors to your site. Here are the 9 most common mistakes we see with landing pages.
The occurrence of Hiatus Hernia is quite common as you get older. Most likely, 50% of the people over 50 will get Hiatus Hernia, and many will not have symptoms. However, if you have pain behind your sternum, breastbone, around your nipple area, and below, this could be because of Hiatus Hernia. The most common area to have pain is behind the breastbone.
Karl Lagerfeld (famous French designer) featured in an advertising video for the yellow safety vest: “it is ugly and fits no one but it could save your life”
The young French start-up, Urban Circus, made this fashion guru’s statement false by creating a collection that has nothing left in common with the yellow safety vest but the norms it follows.
Stylish look, awesome cut, respected norms (EN1150 or ISO 20471), the yellow safety vest is no longer ugly, nor yellow, but a piece of a collection, coming straight from the street and its inspirations. Road safety becomes fun and colorful.
A style that goes along with the new means of transportation and the fabulous success of electrical, modern urban mobility. This jacket was made for this use precisely.
To view the multimedia release go to:
http://www.multivu.com/players/uk/7985151-yellow-safety-high-tech-vest-fashion/
